Research community previously filed under “Molecular Biology”

Gene Therapy, Genome Editing, and Structural Biology for Rare Genetic Diseases

Mostly in the field Ion Channels, Cellular Structure, and Molecular Disease Mechanisms (29% of its papers), one of 5 communities there

Papers 11,934
Elements —
Keywords & sectors 2
Leading venue Molecular Therapy

Gene Therapy, Genome Editing, and Structural Biology for Rare Genetic Diseases

This research community develops gene therapies, genome editing tools, and stem cell treatments for rare genetic disorders, while using high-resolution electron microscopy to determine the structural basis of the proteins involved.

The work centers on adeno-associated virus (AAV) delivery vectors, CRISPR-Cas9 and prime editing technologies, and enzyme replacement therapies. Specific clinical applications include treatments for Pompe disease, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, and hemophilia. The community also investigates hematopoietic and pluripotent stem cells for cell-based therapies and utilizes transmission electron microscopy and electron tomography to resolve protein structures and cellular mechanisms.

The community’s output is distributed across a wide range of elements, with the largest share of research appearing in Zinc, Phosphorus, and Carbon, each accounting for approximately 0.1% of their respective element research. Zinc also contributes the highest number of papers to this group, with 268 entries.

The community comprises 11,934 papers, published primarily in Molecular Therapy, bioRxiv (Cold Spring Harbor Laboratory), and Human Gene Therapy.

Recent work focuses on precise integration of large DNA sequences using retargeted serine integrases and prime assembly with linear DNA donors, as well as the development of potency assays for advanced therapy medicinal products.

Recurring themes in the literature

Phrases that recur across this community's paper titles -- a quick map of its sub-topics, drawn straight from the titles themselves.

  • gene therapy 571
  • pompe disease 312
  • electron microscopy 155
  • genome editing 129
  • alpha-1 antitrypsin 129
  • transmission electron 102
  • adeno-associated virus 96
  • stem cell 90
  • antitrypsin deficiency 89
  • gene editing 79
  • crispr cas9 68
  • stem cells 68
  • hematopoietic stem 66
  • replacement therapy 63
  • muscular dystrophy 63
  • scanning transmission 56
  • mouse model 56
  • pluripotent stem 55
  • electron diffraction 53
  • enzyme replacement 53
  • structural basis 53
  • late-onset pompe 53
  • cell therapy 48
  • duchenne muscular 47

Papers behind this description

Most cited
Signal Transduction and Targeted Therapy · 2024 · 781 citations
New England Journal of Medicine · 2025 · 346 citations
Signal Transduction and Targeted Therapy · 2024 · 414 citations
Nature · 2025 · 205 citations
Nucleic Acids Research · 2022 · 1045 citations
Newest
Nature Biotechnology · 2026 · 17 citations
Science Advances · 2026 · 16 citations
International Journal of Molecular Sciences · 2026 · 12 citations

A sample from the 13 papers behind this description. Create a free account to see them all.